Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, B-Cell

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

122 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

CLL Empirical Antibiotic Regimen

NCT01279252

Conditions: Chronic Lymphocytic Leukaemia (CLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: King's College Hospital NHS Foundation Trust London, United Kingdom

View Trial Details

Completed

Stem Cell Transplantation for Patients With Cancers of the Blood

NCT00467961

Conditions: AML (Acute Myelogenous Leukemia), Acute Lymphocytic Leukemia, Anemia, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Improving Blood Stem Cell Collection and Transplant Procedures

NCT01517035

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, CLL (Chronic Lymphocytic Leukemia), +23 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

NCT01805375

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +22 more
Locations: Royal Liverpool and Broadgreen University Hospital NHS Trust Liverpool, United Kingdom

The Christie NHS Foundation Trust Manchester, United Kingdom

The Churchill Hospital Oxford, United Kingdom

Derriford Hospital Plymouth, United Kingdom

View Trial Details

Completed

Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL

NCT01400685

Conditions: B Chronic Lymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +16 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects

NCT01110031

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: GSK Investigational Site La Jolla, California, United States

GSK Investigational Site Randwick, New South Wales, Australia

GSK Investigational Site Auckland, New Zealand

GSK Investigational Site Christchurch, New Zealand

View Trial Details

Completed

CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.

NCT02132624

Conditions: B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
Locations: Uppsala University Hospital, Dept of Oncology Uppsala, Sweden

View Trial Details

Completed

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

NCT01362452

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia

NCT01077622

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Kanagawa, Japan

GSK Investigational Site Nagasaki, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia

NCT00201721

Conditions: B-Chronic Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details